Skip to main content

Advertisement

SpringerLink
Log in

Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy

  • Case Report
  • Published:
Journal of Orthopaedic Science

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jager PL, Hoekstra HJ, Leeuw JA, van Der Graaf WT, de Vries EG, Piers DA. Routine bone scintigraphy in primary staging of soft tissue sarcoma; is it worthwhile? Cancer 2000;89:1726–1731.

    Article  CAS  PubMed  Google Scholar 

  2. Rehders A, Hosch SB, Scheunemann P, Stoecklein NH, Knoefel WT, Peiper M. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg 2007;142:70–75.

    Article  PubMed  Google Scholar 

  3. Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003;21:4042–4057. Erratum: J Clin Oncol 2004;22:1351.

    Article  CAS  PubMed  Google Scholar 

  4. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases; protocol 19 Aredia Breast Cancer Study Group. N Engl J Med 1996;335:1785–1791.

    Article  CAS  PubMed  Google Scholar 

  5. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 2002;94:1458–1468.

    CAS  PubMed  Google Scholar 

  6. Lipton A, Zheng M, Seaman J. Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer 2003;98:962–969.

    Article  CAS  PubMed  Google Scholar 

  7. Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer 2004;100:2613–2621.

    Article  CAS  PubMed  Google Scholar 

  8. Osanai T, Tsuchiya T, Ogino T, Nakahara K. Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma; a case report. Gynecol Oncol 2006;100:195–197.

    Article  PubMed  Google Scholar 

  9. Vitale G, Fonderico F, Martignetti A, Caraglia M, Ciccarelli A, Nuzzo V, et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 2001;84:1586–1590.

    Article  CAS  PubMed  Google Scholar 

  10. Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993;11:1269–1275.

    CAS  PubMed  Google Scholar 

  11. Yalçin S, Güllü I, Barişta I, Tekuzman G, Ozişik Y, Celik I, et al. Treatment of advanced refractory sarcomas with ifosfamide and etoposide combination chemotherapy. Cancer Invest 1998;16:297–302.

    Article  PubMed  Google Scholar 

  12. Fleisch H. Development of bisphosphonates. Breast Cancer Res 2002;4:30–34.

    Article  CAS  PubMed  Google Scholar 

  13. Bukowski JF, Dascher CC, Das H. Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 2005;328:746–750.

    Article  CAS  PubMed  Google Scholar 

  14. Houston SJ, Rubens RD. The tolerability and adverse event profile of pamidronate disodium. Rev Contemp Pharmacother 1998;9:213–224.

    CAS  Google Scholar 

  15. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005;104:83–93.

    Article  CAS  PubMed  Google Scholar 

  16. Ali SM, Esteva FJ, Hortobagyi G, Harvey H, Seaman J, Knight R, et al. Safety and efficacy of bisphosphonates beyond 24 months in cancer patients. J Clin Oncol 2001;19:3434–3437.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan

    Toshihisa Osanai, Takashi Tsuchiya & Masato Sugawara

Authors
  1. Toshihisa Osanai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masato Sugawara
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Osanai, T., Tsuchiya, T. & Sugawara, M. Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy. J Orthop Sci 14, 224–227 (2009). https://doi.org/10.1007/s00776-008-1300-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00776-008-1300-0

Keywords

Search

Navigation